CopyMark Law Group
4.9/5
Drawing for RAXONE

USPTO serial 78804242

RAXONE

Reviewed by CopyMark Law Group

Reg. 3255290Status 710
Filing date
Status date
Registration date
Jun 26, 2007
Examiner
WATSON, JULIE A
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with RAXONE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Trademark Monitoring
(312) 319-4460
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Start a new application
(312) 319-4460

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Patrick J. Concannon

Patrick J. Concannon Edwards Angell Palmer & Dodge LLPF.D.R. Station, P.O. Box 130New York, NY 10150UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Chemicals used in industry and scienceSECTION 8 - CANCELLED—
005Pharmaceutical, veterinary and sanitary preparations, namely, chemical products for use in the treatment of muscular dystrophy, muscle wasting, atrophy, neuromuscular diseases, cardiomyopathies, ataxias, optic nerve degradation, neurological indications and memory lossSECTION 8 - CANCELLED—
042Computer programming for scientific and industrial research in the fields of cell cultures, muscular dystrophy, muscle wasting, atrophy, neuromuscular diseases, cardiomyopathies, ataxias, optic nerve degradation, neurological indications and memory loss; scientific research for cellular test systems that evaluate drugs and antibodies; scientific research for finding pharmacologically active compounds and animal models for neuromuscular diseases; scientific research in the fields of muscular dystrophy, muscle wasting, atrophy, neuromuscular diseases, cardiomyopathies, ataxias, optic nerve degradation, neurological indications and memory lossSECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 31, 2014C8..CANCELLED SEC. 8 (6-YR)—
May 19, 2010ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 19, 2010REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jun 26, 2007R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 10, 2007PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 21, 2007NPUBNOTICE OF PUBLICATION—
Feb 26, 2007PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Feb 26, 2007CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 23, 2007TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 23, 2007ALIEASSIGNED TO LIE—
Jan 26, 2007CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 26, 2007TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 24, 2007GNSLLETTER OF SUSPENSION E-MAILED—
Jan 24, 2007CNSLSUSPENSION LETTER WRITTEN—
Jan 24, 2007TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 23, 2007CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 23, 2007TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 6, 2006DOCKASSIGNED TO EXAMINER—
Jul 23, 2006GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 23, 2006CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 23, 2006DOCKASSIGNED TO EXAMINER—
Feb 7, 2006NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance